BEER AND THE HEART: INSIGHTS ON THE EFFECTS ON ALCOHOLIC AND NON-ALCOHOLIC BEER

Similar documents
INNOVATION THAT REALLY MATTERS. Prof. Lina Badimon. Institut Català de Ciències Cardiovasculars (ICCC), Barcelona

Reperfusion Injury: How Can We Reduce It?

Ischemia and Reperfusion: Pharmacological treatment options

Ischemic heart disease

Adenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart

Master Eudipharm 2012 Introductory Module, Principles of Discovery of Medicine and Development Planning. Nathan Mewton, MD, PhD. September 26 th 2012

Diagnosis and Management of Acute Myocardial Infarction

Previous MI with no intervention

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

MYOCARDIALINFARCTION. By: Kendra Fischer

Mitochondrial Implications in Coronary Heart Disease. (Pre-Ischemia)

Common Codes for ICD-10

12 Lead EKG Chapter 4 Worksheet

BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.

Myocardial Infarction

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy

Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

Recovering Hearts. Saving Lives.

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension

BEER AND CARDIOVASCULAR HEALTH: EFFECTS ON MORBIDITY AND MORTALITY. Simona Costanzo THE 7 TH EUROPEAN BEER AND HEALTH SYMPOSIUM

Exercise in Adverse Cardiac Remodeling: of Mice and Men

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Small Platform Catheter-Based Left Ventricular Assist Device Support Suppresses Cardioprotective Beta Arrestin- Mediated Signal Transduction

1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).

Sean Davidson. The Hatter Cardiovascular Institute University College London, UK

Journal Club Semmler Lorenz

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Ischemic Heart Diseases. Dr. Nabila Hamdi MD, PhD

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Nuclear medicine in general practice. Dr Reza Garzan MD, FRACP, FAANMS

Diabetes and the Heart

Cardioprotezione ed invecchiamento

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

Consumption of different types of alcohol and mortality

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG.

How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital

Presenter Disclosure Information

Adverse effects of caffeine after a single dose and after repeated doses consumed within a day

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

Reactive oxygen species: Importance for ischemia/reperfusion (injury)

Stable Angina: Indication for revascularization and best medical therapy

Pathophysiology of Coronary Microvascular Dysfunction

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Ischemic Mitral Regurgitation

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias

Microvascular Disease: How to Diagnose and What s its Treatment

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010

FOCUS ON CARDIOVASCULAR DISEASE

Coronary interventions

ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM

Current Indications for Cardiac MRI: What You See is What You Get?

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

12 Lead ECGs: Ischemia, Injury & Infarction. Kevin Handke NRP, FP-C, CCP, CMTE STEMI Coordinator Flight Paramedic

Debate Should we use FFR? I will say NO.

Rational use of imaging for viability evaluation

Personalized Medicine: An

Prevalence of Coronary Artery Disease: A Tertiary Care Hospital Based Autopsy Study

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Acute Myocardial Infarction

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Intervention: How and to which extent is technology helping us?

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Ischemic Heart Disease

FFR in unstable angina and after MI F

The Role of Vitamin D in Heart Disease. Janet Long, MSN, ACNP, CLS, FAHA, FNLA Cardiovascular Institute Rhode Island Hospital and The Miriam Hospital

Sudden cardiac death: Primary and secondary prevention

Maria Angela S. Cruz-Anacleto, MD

EMT. Chapter 14 Review

Cardiovascular Diseases and Diabetes

Metabolic Syndrome. DOPE amines COGS 163

Pre Hospital and Initial Management of Acute Coronary Syndrome

Early Career Investigator Awards. 84 Lipid and Lipoprotein Metabolism: Clinical Lifestyle & Behavioral Medicine

Thyroid hormone and cardiac regeneration: from Prometheus myth to reality

Results of Ischemic Heart Disease

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa

MRI ACS-ben. Tamás Simor MD, PhD, Med Hab. University of Pécs, Heart Institute

Reperfusion Effects After Cardiac Ischemia

(For items 1-12, each question specifies mark one or mark all that apply.)

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

BIOAUTOMATION, 2009, 13 (4), 89-96

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Chest pain affects 20% to 40% of the general population during their lifetime.

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Acute chest pain and ECG need for immediate coronary angiography?

Ginkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury

Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI

Hans Strijdom SA Heart Meeting November 2017

presenters 2010 Sameh Sabet Ain Shams University

MR Assessment of Myocardial Viability

All About STEMIs. Presented By: Brittney Urvand, RN, BSN, CCCC. Essentia Health Fargo Cardiovascular Program Manager.

Transcription:

BEER AND THE HEART: INSIGHTS ON THE EFFECTS ON ALCOHOLIC AND NON-ALCOHOLIC BEER Lina Badimon Cardiovascular Research Center (CRC) CSIC-ICCC Barcelona 7 TH EUROPEAN BEER AND HEALTH SYMPOSIUM BRUSSELS -2014

Mortality causes: impact of CVD WORLD OMS 2010 CVDs LEADING CAUSE OF DEATH (30.5% total)

Recomended doses Alcohol effect on GLOBAL DEATH -30g/day men: 2-3 beers, 2-3 glasses of wine -20g/day women: 1-2 beers, 1-2 glass of wine Corrao et al 2000 - Two drinks per day men - One drink per day women One drink = 12 oz. ( 350 ml) of BEER 4 oz. ( 120ml) of WINE 1.5 oz. ( 45 ml) ofspirits Alcohol intake in young and pregnant = 0

Moderate fermented beverages intake.. Atheroprotective effects (lower incidence of CVD) Cardioprotective effects?

Certain pathological conditions (HYPERCHOLESTEROLEMIA) G. Vilahur, L. Casani, L.Badimon. Atherosclerosis 2012 CARDIAC REMODELING Repair process of the necrotic area promoting myocardial scarring G. Vilahur, O. Juan-Babot, L.Badimon. J Mol Cell Cardiol 2011 Aggravate and/or intensify cardiac structural remodeling adversely affecting cardiac function Beer intake affords cardiac protection and improves scar formation post- AMI in the setting of dyslipidemia???

Study protocol Beer intake affords cardiac protection during ischemia??? 10 days AMI 21 days hypercholesterolemic diet HC CONTROL 12.5g alcohol/day (LOW DOSE) 25g alcohol/day (MODERATE DOSE) 0g alcohol/day (ALCOHOL-FREE) Beer intake affords cardiac protection in the remodeling phase??? SYSTEMS BIOLOGY APPROACH FUNCTIONAL STUDIES CARDIAC FUNCTION CORONARY FUNCTION HISTOLOGICAL STUDIES INFARCT SIZE FIBROSIS / SCAR CARDIAC LIPIDS 0g alcohol/day (ALCOHOL-FREE) 25g alcohol/day (MODERATE DOSE) 12.5g alcohol/day (LOW DOSE) HC CONTROL MOLECULAR STUDIES RISK activation enos activity APOPTOSIS Systemic effects??? SACRIFICE TRANSCRIPTOMICS (ARRAYS)

Cardiac protection during ISCHEMIA?? % episodes VF / animal Incidence of ventricular fibrilations and mortality during STEMI-AMI 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 85,71% 22% Incidence of deaths Incidence of VF 28,57% 0% 0% 0% HC HC+LB HC+MB HC+alcohol-free MB 14,29% 71,43% 4,5 Number of VF/ animal 4 3,5 3 2,5 P<0.05 : AMELIORATES MYOCARDIAL ADAPTATION IN THE SETTING OF ACUTE MI 2 1,5 1,5 0 HC HC+LB HC+MB HC+alcohol-free-MB G. Vilahur, L. Casani, J.Guerra, L.Badimon. Basic Res Cardiol 2012

Cardiac protection post-ami: scar size Scar size /% AAR Coronary artery 50 45 40 35 30 25 20 15 10 5 0 Scar size P=0.07 p=0.068 HC HC+LB HC+MB HC+alcoholfree MB p<0.05 vs HC G. Vilahur, L. Casani, J.Guerra, L.Badimon. Basic Res Cardiol 2012

Scar size and left ventricle remodeling HC HC+LB HC+MB HC+alcoholfree MB 229 ± 11 g 227 ± 10 g 233 ± 9 g 222 ± 7 g :REDUCES SCAR SIZE WITHOUT MODIFYING LV ARCHITECTURE

Cardiac protection post-ami: molecular mechanisms Cardioprotective signaling pathways (RISK) Adenosine Bradykinin Opioids PIP2 PKA PIP3 PDK1 PI3K perk MTP P-eNOS NO GC cgmp PKG PKC Akt P-mdm2 SNO Caspase-3 perk PKC P70S6K p53 GSK BAD MTP APOPTOSIS MTP slow ph recovery

Active Caspase3/βactin Sirt1/18SrRNA Apoptosis execution : :ACTIVATES CARDIOPROTECTIVE KINASES AND REDUCES APOPTOSIS EXECUTION Ischemic Non-Ischemic 300 250 200 Active Caspasa-3 140 120 100 Sirtuin-1 (antioxidant) 150 100 50 80 60 40 20 0 HC HC+LB HC+MB HC+ alcoholfree MB 0 HC HC+LB HC+MB HC+alcoholfree MB p<0.05 vs HC

Apoptosis cell death INFARCT SIZE

WHICH ARE THE GENES INVOLVED IN THE REGULATION OF THE OBSERVED FUNCTIONAL BENEFITS IN THE HEART? TRANSCRIPTOMICS Ischemic border zone G. Vilahur, S. Camino, L. Badimon. Upublished data

Porcine Genome Array - Microarray expression analysis Ischemic border zone 35.000 genes Differential expressed Genes: Software Partek Genomics Suite Networks and functional analysis: Software Ingenuity Pathways Analysis G. Vilahur, S. Camino, L. Badimon. Upublished data

PCA analysis gene cluster HC LB MB G. Vilahur, S. Camino, L. Badimon. Upublished data

Associated Network Functions G. Vilahur, S. Camino, L. Badimon. Upublished data

Systemic vasculoprotective effects

Does been intake improves hypercholesterolemiarelated endothelial dysfunction? 10 days + 12.5g alcohol/day (LOW DOSE) 25g alcohol/day (MODERATE DOSE) 0g alcohol/day (ALCOHOL-FREE) HC CONTROL - CORONARY ENDOTHELIAL FUNCTION - CORONARY OXIDATIVE DNA-DAMAGE Akt/eNOS ACTIVATION G. Vilahur, L. Casani, G. Mendieta, RM. Lamuela-Raventos,R. Estruch, L. Badimon. In review

CORONARY FUNCTION - REACTIVITY Changes in coronary regional blood flow upon pharmacological induction Open-chest approach Fluoroscopy guidance (Rx) LAD Pressure Transducer LAD Myocardium Catheter Circumflex G. Vilahur, L. Casani, G. Mendieta, RM. Lamuela-Raventos,R. Estruch, L. Badimon. Under review

% vasodilation % vasodilation Changes in coronary regional blood flow upon pharmacological induction 120 100 80 60 40 Acetylcholine (M) 120 100 80 60 40 Calcium Ionophore (M) 20 20 0 1,0E-09 1,0E-08 1,0E-07 1,0E-06 0 1,0E-09 1,0E-08 1,0E-07 1,0E-06 120 100 SNP (M) 80 60 40 20 0 1,0E-07 1,0E-06 1,0E-05 G. Vilahur, L. Casani, G. Mendieta, RM. Lamuela-Raventos,R. Estruch, L. Badimon. Under review

CORONARY ARTERY: Akt/eNOS signaling P-Akt/Akt P-eNOS/eNOS 6 5 4 3 2 1 0 HC P-Akt/Akt HC+MD OH-free beer HC+LD Beer HC+MD Beer 3 2 1 0 HC P-eNOS/eNOS HC+MD OH-free beer HC+LD Beer HC+MD Beer P-Akt Akt P-eNOS enos G. Vilahur, L. Casani, G. Mendieta, RM. Lamuela-Raventos,R. Estruch, L. Badimon. Under review

CORONARY ARTERY: DNA-oxidative damage (8-OHdG staining) HC HC+OH-free beer HC+LD Beer HC+MD Beer 8-OHdG G. Vilahur, L. Casani, G. Mendieta, RM. Lamuela-Raventos,R. Estruch, L. Badimon. Under review

TAKE HOME MESSAGES Light-to-moderate regular beer intake (with and without alcohol) during 31 days exerts cardioprotection overcoming the detrimental effects associated with dyslipidemia in the ischemic myocardium Antioxidant properties of beer rather than alcohol in itself may protect against hyperlipemia-induced coronary endothelial dysfunction by favorably counteracting vascular oxidative damage and activating the Akt/eNOS pathway.

Lina Badimon Dra. Laura Casaní Dr. Oriol Juan-Babot Dr. José Mª Guerra (HSCSP) Mª. Angeles Cánovas Pablo Catalina Fco.J. Rodriguez Mª. Angeles Velasco